-
1
-
-
0038187674
-
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
-
DOI 10.1038/nature01640
-
Phiel, C. J., Wilson, C. A., Lee, V. M. & Klein, P. S. GSK-3a regulates production of Alzheimer's disease amyloid-b peptides. Nature 423, 435-439 (2003). (Pubitemid 36626994)
-
(2003)
Nature
, vol.423
, Issue.6938
, pp. 435-439
-
-
Phiel, C.J.1
Wilson, C.A.2
Lee, V.M.-Y.3
Klein, P.S.4
-
2
-
-
0344926464
-
Divergent roles of GSK3 and CDK5 in APP processing
-
DOI 10.1016/j.bbrc.2003.11.014
-
Ryder, J. et al. Divergent roles of GSK3 and CDK5 in APP processing. Biochem. Biophys. Res. Commun. 312, 922-929 (2003). (Pubitemid 37490904)
-
(2003)
Biochemical and Biophysical Research Communications
, vol.312
, Issue.4
, pp. 922-929
-
-
Ryder, J.1
Su, Y.2
Liu, F.3
Li, B.4
Zhou, Y.5
Ni, B.6
-
3
-
-
0142231434
-
751 cells
-
DOI 10.1016/S0014-5793(03)01042-1
-
Li, B. et al. FRAT1 peptide decreases Ab production in swAPP751 cells. FEBS Lett. 553, 347-350 (2003). (Pubitemid 37315628)
-
(2003)
FEBS Letters
, vol.553
, Issue.3
, pp. 347-350
-
-
Li, B.1
Ryder, J.2
Su, Y.3
Zhou, Y.4
Liu, F.5
Ni, B.6
-
4
-
-
2642552331
-
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing
-
DOI 10.1021/bi035627j
-
Su, Y. et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-b precursor protein processing. Biochemistry 43, 6899-6908 (2004). (Pubitemid 38720508)
-
(2004)
Biochemistry
, vol.43
, Issue.22
, pp. 6899-6908
-
-
Su, Y.1
Ryder, J.2
Li, B.3
Wu, X.4
Fox, N.5
Solenberg, P.6
Brune, K.7
Paul, S.8
Zhou, Y.9
Liu, F.10
Ni, B.11
-
5
-
-
33750894549
-
Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease
-
Huang, H. C. & Klein, P. S. Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease. Curr. Drug Targets 7, 1389-1397 (2006). (Pubitemid 44718299)
-
(2006)
Current Drug Targets
, vol.7
, Issue.11
, pp. 1389-1397
-
-
Huang, H.-C.1
Klein, P.S.2
-
6
-
-
33846181973
-
Targeting glycogen synthase kinase-3 in Alzheimer's disease
-
DOI 10.1016/j.ddstr.2006.10.020, PII S1740677306000829
-
Huang, H. C., O'Brien, W. T. & Klein, P. S. Targeting glycogen synthase kinase-3 in Alzheimer's disease. Drug Discov. Today Ther. Strateg. 3, 613-619 (2006). (Pubitemid 46083337)
-
(2006)
Drug Discovery Today: Therapeutic Strategies
, vol.3
, Issue.4
, pp. 613-619
-
-
Huang, H.-C.1
O'Brien, W.T.2
Klein, P.S.3
-
7
-
-
83055188883
-
GSK-3a/b kinases and amyloid production in vivo
-
doi:10.1038/nature10615
-
Jaworski, T. et al. GSK-3a/b kinases and amyloid production in vivo. Nature 480, doi:10.1038/nature10615 (2011).
-
(2011)
Nature
, vol.480
-
-
Jaworski, T.1
-
8
-
-
0037383322
-
GSK-3: Tricks of the trade for a multi-tasking kinase
-
DOI 10.1242/jcs.00384
-
Doble, B. W. & Woodgett, J. R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186 (2003). (Pubitemid 36410657)
-
(2003)
Journal of Cell Science
, vol.116
, Issue.7
, pp. 1175-1186
-
-
Doble, B.W.1
Woodgett, J.R.2
-
9
-
-
34249311572
-
Functional Redundancy of GSK-3α and GSK-3β in Wnt/β-Catenin Signaling Shown by Using an Allelic Series of Embryonic Stem Cell Lines
-
DOI 10.1016/j.devcel.2007.04.001, PII S1534580707001487
-
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K. & Woodgett, J. R. Functional redundancy of GSK-3a and GSK-3b inWnt/b-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957-971 (2007). (Pubitemid 46805920)
-
(2007)
Developmental Cell
, vol.12
, Issue.6
, pp. 957-971
-
-
Doble, B.W.1
Patel, S.2
Wood, G.A.3
Kockeritz, L.K.4
Woodgett, J.R.5
-
10
-
-
0037087220
-
Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100
-
DOI 10.1016/S0304-3940(01)02583-6, PII S0304394001025836
-
Sun, X. et al. Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci. Lett. 321, 61-64 (2002). (Pubitemid 34185499)
-
(2002)
Neuroscience Letters
, vol.321
, Issue.1-2
, pp. 61-64
-
-
Sun, X.1
Sato, S.2
Murayama, O.3
Murayama, M.4
Park, J.-M.5
Yamaguchi, H.6
Takashima, A.7
-
11
-
-
68149150844
-
A novel GSK-3b inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
-
Serenó, L. et al. A novel GSK-3b inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol. Dis. 35, 359-367 (2009).
-
(2009)
Neurobiol. Dis.
, vol.35
, pp. 359-367
-
-
Serenó, L.1
|